JohnsonD.W., DentH., HawleyC.M., McDonaldS.P., RosmanJ.B., BrownF.G.Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand.Am J Kidney Dis2009; 53: 290–7.
3.
GhaliJ.R., BannisterK.M., BrownF.G., RosmanJ.B., WigginsK.J., JohnsonD.W.Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients.Perit Dial Int2011; :[Epub ahead of print].
4.
JoseM.D., JohnsonD.W., MudgeD.W., TranæusA., VossD., WalkerR.Peritoneal dialysis practice in Australia and New Zealand: a call to action.Nephrology (Carlton)2011; 16: 19–29.
5.
TielensE., NubéM.J., de VetJ.A., van LimbeekJ., HofmanX., SteffensA.Major reduction of CAPD peritonitis after the introduction of the twin-bag system.Nephrol Dial transplant1993; 8: 1237–43.
6.
StrippoliG.F., TongA., JohnsonD., SchenaF.P., CraigJ.C.Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients.Cochrane Database Syst Rev2004; (4): CD004680.
7.
StrippoliG.F., TongA., JohnsonD., SchenaF.P., CraigJ.C.Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials.J Am Soc Nephrol2004; 15: 2735–46.
8.
StrippoliG.F., TongA., JohnsonD., SchenaF.P., CraigJ.C.Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.Cochrane Database Syst Rev2004; (4): CD004679.
9.
StrippoliG.F., TongA., JohnsonD., SchenaF.P., CraigJ.C.Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials.Am J Kidney Dis2004; 44: 591–603.
10.
PirainoB.Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Was it effective?Nephrol Dial transplant2010; 25: 349–52.
KimD.K., YooT.H., RyuD.R., XuZ.G., KimH.J., ChoiK.H.Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade.Perit Dial Int2004; 24: 424–32.
13.
Muñoz de BustilloE., AguileraA., JiménezC., BajoM.A., SánchezC., SelgasR.Streptococcal versus Staphylococcus epidermidis peritonitis in CAPD. A comparative study.Perit Dial Int1997; 17: 392–5.
14.
BunkeC.M., BrierM.E., GolperT.A.Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study.Kidney Int1997; 52: 524–9.
15.
EdeyM., HawleyC.M., McDonaldS.P., BrownF.G., RosmanJ.B., WigginsK.J.Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases.Nephrol Dial transplant2010; 25: 1272–8.
SutherlandS.M., AlexanderS.R., FenebergR., SchaeferF., WaradyBA on behalf of the International Pediatric Peritonitis Registry (IPPR). Enterococcal peritonitis in children receiving chronic peritoneal dialysis.Nephrol Dial transplant2010; 25: 4048–54.
18.
YipT., TseK.C., NgF., HungI., LamM.F., TangS.Clinical course and outcomes of single-organism Enterococcus peritonitis in peritoneal dialysis patients.Perit Dial Int2011; 31: 522–528.
19.
SzetoC.C., ChowV.C., ChowK.M., LaiR.W., ChungK.Y., LeungC.B.Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases.Kidney Int2006; 69: 1245–52.